Non-interventional safety study on the tolerability and safety of octagam® 5%, octagam® 10% or panzyga®

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS7687
• Study ID:
  46952
• Official title and acronym:
  Non-interventional safety study on the tolerability and safety of octagam® 5%, octagam® 10% or panzyga®
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  No information provided.
• Study status:
  Finalised

Research institutions and networks

Institutions

Octapharma

Multiple centres: 200 centres are involved in the study

Study timelines

Date when funding contract was signed

Planned:01/01/2014

Actual:01/01/2014

Study start date

Planned:01/01/2014

Actual:07/03/2014

Date of final study report

Planned:31/12/2021

Actual:24/01/2022

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Octapharma GmbH

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable